Rivaroxaban does not increase hemorrhage after thrombolysis in experimental ischemic stroke

The management of acute ischemic stroke during anticoagulation with a novel oral anticoagulant (NOAC) is challenging because intravenous thrombolysis is contrai...

Saved in:
Bibliographic Details
Main Authors: Ploen, Robert (Author) , Sun, Li (Author) , Zhou, Wei (Author) , Heitmeier, Stefan (Author) , Zorn, Markus (Author) , Jenetzky, Ekkehart (Author) , Veltkamp, Roland (Author)
Format: Article (Journal)
Language:English
Published: 2014
In: Journal of cerebral blood flow & metabolism
Year: 2013, Volume: 34, Pages: 495-501
ISSN:1559-7016
DOI:10.1038/jcbfm.2013.226
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/jcbfm.2013.226
Verlag, lizenzpflichtig, Volltext: https://journals.sagepub.com/doi/10.1038/jcbfm.2013.226
Get full text
Author Notes:Robert Ploen, Li Sun, Wei Zhou, Stefan Heitmeier, Markus Zorn, Ekkehart Jenetzky and Roland Veltkamp
Description
Summary:The management of acute ischemic stroke during anticoagulation with a novel oral anticoagulant (NOAC) is challenging because intravenous thrombolysis is contrai...
Item Description:Published: December 18, 2013
Gesehen am 16.09.2020
Physical Description:Online Resource
ISSN:1559-7016
DOI:10.1038/jcbfm.2013.226